一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

ChemicalBook >> journal list >> British Journal of Pharmacology >>article
British Journal of Pharmacology

British Journal of Pharmacology

IF: 6.8
Download PDF

PPARγ is a potential therapeutic target for radiation enteritis via suppressing ferroptosis, mediated by the GAPDH/glycosylation axis

Published:13 May 2025 DOI: 10.1111/bph.70045 PMID: 40361259
Xi Zeng, Liefeng Zhang, Hong Lu, Xinru Xue, Ling Yang, Xiuling Yang, Zhuohui Liu, Xiaoying Cao, Yue Dai, Zhifeng Wei

Abstract

Background and Purpose

Radiation enteritis (RE) is a severe complication after radiotherapy with no specific therapeutic agents. Here, we have attempted to identify the key therapeutic targets for RE, to advance drug development.

Experimental Approach

Therapeutic targets were screened and identified using RE patients' intestinal samples, bioinformatics, and mouse models. RNA sequencing, electron microscopy, metabolomics, glycolytic flux, co-immunoprecipitation, molecular docking, point mutation were used to identify mechanisms.

Key Results

Analysis of gene changes in response to ionising radiation showed extensive regulation of several differentially expressed genes by PPARγ, as well as its deficiency in activation and expression in RE. Both activation and overexpression of PPARγ significantly antagonised RE in vivo. Mechanistically, PPARγ specifically limited ferroptosis in intestinal epithelial cells exposed to ionising radiation, and its selective activation was more effective than full activation because of the reduced effect on the ferroptosis-driving genes PTEN and SAT1. Furthermore, ionising radiation caused the greatest changes in glucose metabolism. PPARγ targeted GAPDH at Lys107 to shift glycolysis to the hexosamine biosynthesis pathway, thereby enhancing glycosylation. In ionising radiation-induced ferroptosis, O/N-GlcNAcylation initially played antagonistic roles and later mediated the process, and they assisted PPARγ in restraining lysosomal degradation of heavy-chain ferritin (FTH1) and the transferrin receptor TFRC, thus controlling storage and transport of iron, and consequently alleviated ferroptosis.

Conclusion and Implications

PPARγ is a potential therapeutic target for RE, as it elicits GAPDH-mediated glucose metabolic reprogramming and alleviates ionising radiation-induced ferroptosis, in a glycosylation-dependent manner.

Substances (20)

Materials
Procduct Name CAS Molecular Formula Supplier Price
Rosiglitazone 122320-73-4 C18H19N3O3S 556 suppliers $8.00-$970.00
Rosiglitazone 122320-73-4 C18H19N3O3S 556 suppliers $8.00-$970.00
Rosiglitazone 122320-73-4 C18H19N3O3S 556 suppliers $8.00-$970.00
Rosiglitazone 122320-73-4 C18H19N3O3S 556 suppliers $8.00-$970.00
2-[1-[4-[2-(4-Chlorophenoxy)acetyl]-1-piperazinyl]ethyl]-3-(2-ethoxyphenyl)-4(3H)-Quinazolinone 571203-78-6 C30H31ClN4O4 284 suppliers $16.00-$2691.10
2-[1-[4-[2-(4-Chlorophenoxy)acetyl]-1-piperazinyl]ethyl]-3-(2-ethoxyphenyl)-4(3H)-Quinazolinone 571203-78-6 C30H31ClN4O4 284 suppliers $16.00-$2691.10
2-[1-[4-[2-(4-Chlorophenoxy)acetyl]-1-piperazinyl]ethyl]-3-(2-ethoxyphenyl)-4(3H)-Quinazolinone 571203-78-6 C30H31ClN4O4 284 suppliers $16.00-$2691.10
2-[1-[4-[2-(4-Chlorophenoxy)acetyl]-1-piperazinyl]ethyl]-3-(2-ethoxyphenyl)-4(3H)-Quinazolinone 571203-78-6 C30H31ClN4O4 284 suppliers $16.00-$2691.10
RSL3 1219810-16-8 C23H21ClN2O5 218 suppliers $13.00-$1872.00
RSL3 1219810-16-8 C23H21ClN2O5 218 suppliers $13.00-$1872.00
怀仁县| 乐业县| 屯昌县| 通山县| 河西区| 屯门区| 涞水县| 柯坪县| 忻州市| 宽甸| 章丘市| 呼玛县| 庄河市| 任丘市| 大名县| 河北区| 雅江县| 惠州市| 称多县| 临泽县| 祥云县| 竹溪县| 新干县| 普陀区| 兰坪| 浠水县| 瑞金市| 泾川县| 梧州市| 遵化市| 龙南县| 临夏市| 德清县| 平舆县| 略阳县| 中阳县| 海伦市| 金乡县| 延庆县| 建昌县| 枝江市|